Q3 2018 Holdings
Filed 2018-11-14 | 5 holdings | $53.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Urogen Pharma Ltd.(URGN) | Common Stock | M96088105 | $37.3K | 789,297 | 70.4% |
| Mersana Therapeutics, Inc. | Common Stock | 59045L106 | $9.6K | 955,709 | 18.0% |
| Immune Design Corp. | Common Stock | 45252L103 | $4.3K | 1,236,394 | 8.1% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common Stock | 00847L100 | $1.9K | 5,062,363 | 3.5% |